HOME  >  Pipelines




GM102 is an oncolytic adenovirus that promotes degradation of tumor extracellular matrix and inhibits pro-metastatic signaling pathways of tumor

Indication: Pancreatic cancer

Development Stage: pre-clinical/preparing phase I clinical trial

Description 1. GM102 effectively degrades tumor extracellular matrix in highly desmoplastic pancreatic tumors to maximize intratumoral virus dispersion, immune cell infiltration, and distribution of cancer treatment modalities 2. GM102 treatment synergistically enhances the therapeutic potential of conventional cancer treatment modalities 3. GM102 effectively inhibits metastasis-associated signaling pathway and suppresses metastasis of tumor

GM102 Data